Second Biomarker Expert Meeting in Heidelberg
Numerous experts in molecular diagnostics convened at the Second Workshop of the Biomarker Discovery Center (BDC, www.bd…
Numerous experts in molecular diagnostics convened at the Second Workshop of the Biomarker Discovery Center (BDC, www.bd…
febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes.…
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the…
The Molecular Genetics Core Facility (MGCF) at Children's Hospital Boston chose febit's HybSelect technology which will…
febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazin…
febit's HybSelectTM technology for sequence capture combined with Applied Biosystems' SOLiD(TM) System enable automated,…
febit's HybSelectTM technology for sequence capture enables targeted Next-Generation Sequencing, furthers development of…
febit holding gmbh announced today the launch of the first biochip on the market covering the newly published whole mous…
febit holding gmbh announced today, that the company has been granted the first European patent (EP1436609) for a microa…
febit today announced the official launch of its new sequence capture technology Hybselect. In several biomedical studie…